Crossmark

Necessity of 45-Day Transesophageal Echocardiography After the WATCHMAN Procedure Amid the COVID-19 Pandemic

Crossref DOI link: https://doi.org/10.1016/j.jcmg.2020.05.015

Published Print: 2020-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tan, Bryan E-Xin

Depta, Jeremiah P.

Baibhav, Bipul

Bhatt, Deepak L.
Funding

Funding for this research was provided by:

St. Jude Medical

Novo Nordisk

Duke Clinical Research Institute

Ferring Pharmaceuticals

Edwards Lifesciences

Icahn School of Medicine at Mount Sinai

Belvoir Media Group

American College of Cardiology Foundation

Daiichi-Sankyo

Abbott Laboratories

CSL Behring

Bristol-Myers Squibb

Boston Scientific Corporation

AstraZeneca

Bayer Fund

Merck

Cleveland Clinic

Boehringer Ingelheim

Takeda Pharmaceuticals U.S.A.

Mayo Clinic
License Information

Text and Data Mining valid from 2020-11-01

Text and Data Mining valid from 2020-11-01

Version of Record valid from 2021-11-01
More Information

This article is maintained by: Elsevier

Article Title: Necessity of 45-Day Transesophageal Echocardiography After the WATCHMAN Procedure Amid the COVID-19 Pandemic

Journal Title: JACC: Cardiovascular Imaging

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jcmg.2020.05.015

Content Type: simple-article

Copyright: © 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation